MedPath

Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer

Not Applicable
Conditions
Bronchial Cancer
Interventions
Device: With and without SDB
Registration Number
NCT02648087
Lead Sponsor
University Hospital, Angers
Brief Summary

There is a possible implication of sleep apnea syndrome via night-time intermittent hypoxemia in perturbation of quality of life and tumour progression to patients with a bronchial cancer.

The aim of the study is to evaluate this possibility with the help of a night record of sleep and quality of life questionnaires.

Detailed Description

There is a possible implication of sleep apnea syndrome via night-time intermittent hypoxemia in perturbation of quality of life and tumour progression to patients with a bronchial cancer.

Enrollment 1200 patients This wide sample is expected to respond to the main and secondary objectives of the study

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1200
Inclusion Criteria
  • patients with NSCLC undergoing diagnostic
  • Performance status 0,1,2
Exclusion Criteria
  • >75 years
  • OSA known and in the last 12 months treated PS >2
  • Patients under a long-term oxygen therapy
  • persons deprived of liberty by judicial decision.
  • <18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
With and without SDBWith and without SDBcomparison of patients with and without sleep-disordered breathing
Primary Outcome Measures
NameTimeMethod
Oxygen desaturation indexBetween day 1 and day 15

RECORDING BY POLYGRAPHY DEVICE between day 1 and day 15 after enrollment

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath